Biomedical engineers have developed a self-assembling nanomaterial that can help limit damage caused by inflammatory diseases by activating key cells in the immune system. In mouse models of psoriasis, the team showed that their nanofiber-based drug could effectively mitigate damaging inflammation as effectively as a gold-standard therapy.
